No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
MRNA Moderna
- 101.410
- -0.590-0.58%
Close Apr 19 16:00 ET
- 101.855
- +0.445+0.44%
Post 19:41 ET
38.83BMarket Cap-8224P/E (TTM)
103.795High100.450Low2.67MVolume102.370Open102.000Pre Close271.44MTurnover0.77%Turnover RatioLossP/E (Static)382.88MShares142.79052wk High2.80P/B35.41BFloat Cap62.55052wk Low--Dividend TTM349.18MShs Float497.490Historical High--Div YieldTTM3.28%Amplitude11.540Historical Low101.646Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Unusual Options Activity: COHR, APLS and Others Attract Market Bets, COHR V/OI Ratio Reaches 294.1
EST Apr 19th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trend
Moderna Stock on Track for the Eighth Consecutive Day of Losses
Moderna (MRNA) Stock Moves -0.34%: What You Should Know
Form 144 | Moderna(MRNA.US) Director Proposes to Sell 1.56 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 17, $Moderna(MRNA.US)$ Director NOUBAR B AFEYAN intends to sell 15,000 shares of its common stock on Apr 17, with a total market value of approximately $1.56 million. NOU
How Moderna's CIO Helps Steer the Drugmaker's Post-COVID Evolution
Moderna Options Trading: A Deep Dive Into Market Sentiment
High-rolling investors have positioned themselves bearish on Moderna (NASDAQ:MRNA), and it's important for retail traders to take note.\This activity came to our attention today through Benzinga's tra
Comments
$Moderna(MRNA.US$ can you go up 1 day, i beg you
1
Novavax to Supply Updated COVID-19 Vaccine to Private Healthcare Providers in the United Kingdom
$Novavax(NVAX.US$$Moderna(MRNA.US$
April 18, 2024
For Global Investor Audience Only
Novavax’s Nuvaxovid XBB.1.5 dispersion for injection, COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601) is now available to pharmacies across the United Kingdom (U.K.) for private healthcare providers to offer an updated protein-based non-mRNA option as part of the 2024 vaccination season.
To...
April 18, 2024
For Global Investor Audience Only
Novavax’s Nuvaxovid XBB.1.5 dispersion for injection, COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601) is now available to pharmacies across the United Kingdom (U.K.) for private healthcare providers to offer an updated protein-based non-mRNA option as part of the 2024 vaccination season.
To...
1
ESPR is the Probably the Most Undervalued Stock on the Market, Offers 2500% Upside. 2 FDA Approved Blockbuster Drugs. Billions in Sales Expected. Buyout Expected.
$Esperion Therapeutics(ESPR.US$ Esperion (ESPR) stock price has dropped from a recent high of $3.40 a share to $2.31 on FALSE claims of dilution. The price drop offers an amazing buying opportunity.
Huge News On Mar 25.2024 U.S. FDA Approved Broad Labels for NEXLIZET and NEXLETOL, now regular doctors can prescribe and Insurance will...
Huge News On Mar 25.2024 U.S. FDA Approved Broad Labels for NEXLIZET and NEXLETOL, now regular doctors can prescribe and Insurance will...
3
ColumnsToday's Morning Movers and Top Ratings: DAL, MRNA, ALB and More
Morning Movers
Gapping up
$Delta Air Lines(DAL.US$ stock rose 4.3% following the airline's optimistic outlook for the current quarter, bolstered by strong travel demand that led to first-quarter earnings surpassing estimates.
$Moderna(MRNA.US$ stock increased by 0.6%, building on the previous session's 6% gain, after the company released promising cancer-vaccine data, indicating potential effectiveness beyond just melanoma.
$Taiwan Semiconductor(TSM.US$ stock gr...
Gapping up
$Delta Air Lines(DAL.US$ stock rose 4.3% following the airline's optimistic outlook for the current quarter, bolstered by strong travel demand that led to first-quarter earnings surpassing estimates.
$Moderna(MRNA.US$ stock increased by 0.6%, building on the previous session's 6% gain, after the company released promising cancer-vaccine data, indicating potential effectiveness beyond just melanoma.
$Taiwan Semiconductor(TSM.US$ stock gr...
20
FDA PDUFA Update…
🗓️ Last week’s PDUFAs:
$Supernus Pharmaceuticals(SUPN.US$ : CRL 4/8/24 🙁
⇒ SPN-830
⇒ OFF episodes in PD
⇒ NDA
⇒ PDUFA: 4/5/24
$Legend Biotech(LEGN.US$ & $Johnson & Johnson(JNJ.US$ : Approved 🎉
⇒ CARVYKTI (cilta-cel)
⇒ Multiple myeloma
⇒ sBLA
⇒ PDUFA: 4/5/24
$AstraZeneca(AZN.US$ : Approved 🎉
⇒ Enhertu
⇒ HER2+ solid tumors
⇒ sBLA
⇒ PDUFA: Q2 2024
$2seventy bio(TSVT.US$ & $Bristol-Myers Squibb(BMY.US$ : Approved 🎉
⇒ Abecma
⇒ Multiple myeloma
⇒ sBLA
⇒ Delayed PDUFA
$Vanda Pharmaceuticals(VNDA.US$...
$Supernus Pharmaceuticals(SUPN.US$ : CRL 4/8/24 🙁
⇒ SPN-830
⇒ OFF episodes in PD
⇒ NDA
⇒ PDUFA: 4/5/24
$Legend Biotech(LEGN.US$ & $Johnson & Johnson(JNJ.US$ : Approved 🎉
⇒ CARVYKTI (cilta-cel)
⇒ Multiple myeloma
⇒ sBLA
⇒ PDUFA: 4/5/24
$AstraZeneca(AZN.US$ : Approved 🎉
⇒ Enhertu
⇒ HER2+ solid tumors
⇒ sBLA
⇒ PDUFA: Q2 2024
$2seventy bio(TSVT.US$ & $Bristol-Myers Squibb(BMY.US$ : Approved 🎉
⇒ Abecma
⇒ Multiple myeloma
⇒ sBLA
⇒ Delayed PDUFA
$Vanda Pharmaceuticals(VNDA.US$...
9
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
70133785 : 医药板块都不行，老男人
so weak